The Merck Medical Outreach Program · –Former U.S. President Jimmy Carter ... abroad. Donations for use in ... their on-going, humanitarian programs. Says Kara Keating, of CMMB,

than 120,000 local communities — all of which have

joined together to help bring MECTIZAN to those in

need over the past two decades. The MDP has been

hailed by many as a landmark program involving

collaboration between a private pharmaceutical

company and the public sector, working together

in pursuit of far-reaching humanitarian goals.

Merck is proud that the program now serves as a

model for similar healthcare initiatives.

I think Merck has set a standard of the

highest possible quality. It’s been one

of the most remarkable and exciting

partnerships that I have ever witnessed.

–Former U.S. President Jimmy Carter

More information on the MECTIZAN Donation Program may be obtained from:

MECTIZAN Donation Program Secretariat750 Commerce Drive, Suite 400Decatur, GA 30030 USA

or online at www.mectizan.org

The Merck Medical Outreach Program

FOR ADDITIONAL INFORMATION on the Merck

Medical Outreach Program, please contact:

Ken GustavsenManager, Global Product Donations

Christine FunkAssociate Manager, Corporate Contributions

Mary Alice MerkBusiness Support Coordinator

Merck & Co., Inc.One Merck DriveP.O. Box 100 (WS 1A-17)Whitehouse Station, NJ 08889-0100Phone: 908-423-1000Fax: 908-423-1987

To learn more about corporate responsibility at Merck, please visit www.Merck.com/cr

Merck & Co., Inc., Whitehouse Station, NJ, USA (“Merck”)*

is a global research-driven pharmaceutical company dedicated

to putting patients first. Established in 1891, Merck discovers,

develops, manufactures and markets vaccines and medicines to

address unmet medical needs. The company also devotes extensive

efforts to increase access to medicines through far-reaching

programs that not only donate Merck medicines but help deliver

them to the people who need them. Merck’s product donations

program, known as The Merck Medical Outreach Program, is one

channel through which Merck accomplishes this mission.

The Merck Medical Outreach Program (MMOP) was established

within the Office of Contributions of Merck & Co., Inc. in 1958.

Through this program Merck donates critical pharmaceuticals

and vaccines to a limited number of qualified, US-based,

private voluntary organizations (PVOs) for use in their on-going,

humanitarian programs in the developing world, and in support

of major disaster relief efforts within the United States and

abroad. Donations for use in the United States or other devel-

oped countries are generally not made through this program,

except in disaster/emergency situations.

The scope of the MMOP varies from year to year and is

influenced by changing medical needs in developing countries,

the quantity of Merck medicines available for donation, and

the random nature of natural and man-made disasters.

Donations of Merck medicines, with the exception of MECTIZANTM,

are made primarily through six qualified 501(c)(3) PVOs —

AmeriCares, Catholic Medical Mission Board (CMMB), Direct Relief

International, Interchurch Medical Assistance, Inc. (I. M. A.),

MAP International and Project HOPE. Each of these organizations

has a long-standing relationship with the Company, demonstrates

integrity of purpose; provides assurance that Merck products will

be securely warehoused and will not be diverted, mishandled or

misappropriated; and has well-established programs for the ill

and needy in developing countries. Such direction provides the

Company with the controls necessary for the proper distribution

and handling of Merck medicines through this program. Merck

does not provide donations to individuals, medical missions, or

donations of expired products or products that do not have adequate

dating to allow for proper administration prior to expiration.

Cover photo courtesy of AmeriCares.

© 2006 Merck & Co., Inc. All rights reserved.*Merck & Co., Inc., operates as Merck Sharp & Dohme (MSD) in most countries outside theUnited States.

THE MERCK ANNUAL PRODUCT ALLOTMENT PROGRAM allows six PVOs to order fully dated material of their choice

from the Company’s current product line — up to an annually authorized amount. The first program of its kind in the

industry, it has served as a model for pharmaceutical companies who have established similar programs. Jodi Allison,

Account Manager of Corporate Relations at MAP International, observes, “Allowing PVOs to order specific medicines of their

own choice enables us ultimately to get the most needed medicines to those who have the greatest need. It also enables

PVOs to plan more effectively and to provide continued treatment of particular therapies. In a world where nearly half

the population still lacks regular access to basic healthcare, let alone essential medicines, this is extremely helpful.”

EXCESS PHARMACEUTICALS AND VACCINES are available to Merck’s Office of Contributions for donation by the

Merck Manufacturing Division (MMD) and the Merck Vaccine Division (MVD), and are regularly offered to the PVOs for use in

their on-going, humanitarian programs. Says Kara Keating, of CMMB, “In addition to supporting CMMB with a sustainable

supply of medicines through the Annual Allotment program, Merck responded to CMMB’s call for action in providing 100,000

doses of Measles, Mumps, and Rubella vaccine for CMMB’s Back to Haiti Initiative for child health. With Merck's support,

CMMB continues to provide quality healthcare programs and services to people in need worldwide.”

DISASTER AND EMERGENCY RELIEF The Merck Office of Contributions responds to disaster and emergency relief

situations around the world and acts as the clearinghouse within Merck for coordinating a Company-wide response to

major medical emergencies and disasters. Each disaster relief request is evaluated and handled on a case-by-case basis.

The Office of Contributions relies on the PVOs to communicate with in-country partners and staff, as well as affected

Ministries of Health, to provide accurate needs assessments. Working with the PVOs, Merck’s inventory planning

groups, the Merck Vaccine Division and local country management, the Office of Contributions determines an appropriate

response to disaster situations. Recently, donations of Merck medicines and vaccines played an important role in support

of relief efforts for areas affected by:

• The Southeast Asia Tsunami in 2004 $7.5 million inMerck medicines and vaccines

• Hurricanes Katrina and Rita in the United States in 2005

$11 million in Merck medicines and vaccines

• The earthquake in Pakistan in 2005 $95,000 in Merck medicines and vaccines

Dr. John P. Howe III, President and CEO of Project HOPE,

notes, “Merck is one of Project HOPE’s most reliable and

compassionate partners. From the historic first mission of

the S.S. HOPE nearly 50 years ago, to our hurricane, earth-

quake and tsunami relief efforts of recent times, Merck has

been at our side helping to bring life-saving health care

resources and hope to the people who need them most.”

the lymphatic system. Those affected may develop kidney

damage due to blockage of the lymphatic system. The

disease is commonly known as elephantiasis because it

can lead to the disfiguring enlargement of the arms, legs

and genitals. More than 300 million people in Africa are

at risk of contracting LF.

In 1998, Merck committed to donating MECTIZAN for the

elimination of LF in African countries where it co-exists

with onchocerciasis. Merck’s MECTIZAN is a key component

of the Global Alliance for the Elimination of Lymphatic

Filariasis (GAELF), which has the goal of eliminating LF

worldwide by the year 2020. By 2006, national LF elimina-

tion programs using MECTIZAN had been established in

10 African countries, with an estimated 40 million people

receiving the medication.

The MECTIZAN Donation Program is the largest, continuing

donation program of its kind, involving a unique and

unprecedented collaboration amongst Merck, the World

Health Organization, the World Bank, UNICEF, numerous

non-governmental development organizations and

international agencies, Ministries of Health and more

MERCK MECTIZAN DONATION PROGRAM (MDP)Now marking its 20th year, the Merck MECTIZAN Donation

Program (MDP) for the treatment of onchocerciasis (river

blindness) and elimination of lymphatic filariasis is the

largest component of the MMOP. Merck decided to donate

MECTIZANTM for the treatment of river blindness for as long

as needed, wherever needed, in 1987. In 1998, Merck

expanded the MDP to include the elimination of

lymphatic filariasis in African countries where

lymphatic filariasis and onchocerciasis co-exist.

Onchocerciasis is endemic in 35 countries throughout

sub-Saharan Africa, Latin America and in Yemen, with

an estimated 120 million people in these areas at risk

of contracting the disease. The disease is caused

by a parasitic worm that is transmitted (to infected

individuals) by the bite of a black fly that breeds

in fast-flowing rivers. A debilitating parasitic disease

that causes excruciating itching and severe disfigure-

ment, onchocerciasis is a leading cause of preventable

blindness in Central and West Africa.

Merck donates MECTIZAN to non-governmental development

organizations (NGDOs) — working in conjunction with local

Ministries of Health — for the treatment of large populations

in countries where onchocerciasis is endemic. Applications

to implement community-directed treatment programs are

submitted to the MECTIZAN Donation Program Secretariat for

review and approval by the MECTIZAN Expert Committee.

The Merck MECTIZAN Donation Program has successfully reached

millions at risk in some of the poorest regions in the world.

In 2006 alone, more than 60 million people were treated for

onchocerciasis with MECTIZAN.

Lymphatic filariasis, (LF) commonly referred to as elephantiasis,

is a disease found in the tropics and sub-tropics of Africa, Asia,

the Western Pacific and parts of the Americas. The parasitic

filarial worms are transmitted by a mosquito and lodge in Photo courtesy of Interchurch Medical Assistance, Inc.

THE MERCK ANNUAL PRODUCT ALLOTMENT PROGRAM allows six PVOs to order fully dated material of their choice

from the Company’s current product line — up to an annually authorized amount. The first program of its kind in the

industry, it has served as a model for pharmaceutical companies who have established similar programs. Jodi Allison,

Account Manager of Corporate Relations at MAP International, observes, “Allowing PVOs to order specific medicines of their

own choice enables us ultimately to get the most needed medicines to those who have the greatest need. It also enables

PVOs to plan more effectively and to provide continued treatment of particular therapies. In a world where nearly half

the population still lacks regular access to basic healthcare, let alone essential medicines, this is extremely helpful.”

EXCESS PHARMACEUTICALS AND VACCINES are available to Merck’s Office of Contributions for donation by the

Merck Manufacturing Division (MMD) and the Merck Vaccine Division (MVD), and are regularly offered to the PVOs for use in

their on-going, humanitarian programs. Says Kara Keating, of CMMB, “In addition to supporting CMMB with a sustainable

supply of medicines through the Annual Allotment program, Merck responded to CMMB’s call for action in providing 100,000

doses of Measles, Mumps, and Rubella vaccine for CMMB’s Back to Haiti Initiative for child health. With Merck's support,

CMMB continues to provide quality healthcare programs and services to people in need worldwide.”

DISASTER AND EMERGENCY RELIEF The Merck Office of Contributions responds to disaster and emergency relief

situations around the world and acts as the clearinghouse within Merck for coordinating a Company-wide response to

major medical emergencies and disasters. Each disaster relief request is evaluated and handled on a case-by-case basis.

The Office of Contributions relies on the PVOs to communicate with in-country partners and staff, as well as affected

Ministries of Health, to provide accurate needs assessments. Working with the PVOs, Merck’s inventory planning

groups, the Merck Vaccine Division and local country management, the Office of Contributions determines an appropriate

response to disaster situations. Recently, donations of Merck medicines and vaccines played an important role in support

of relief efforts for areas affected by:

• The Southeast Asia Tsunami in 2004 $7.5 million inMerck medicines and vaccines

• Hurricanes Katrina and Rita in the United States in 2005

$11 million in Merck medicines and vaccines

• The earthquake in Pakistan in 2005 $95,000 in Merck medicines and vaccines

Dr. John P. Howe III, President and CEO of Project HOPE,

notes, “Merck is one of Project HOPE’s most reliable and

compassionate partners. From the historic first mission of

the S.S. HOPE nearly 50 years ago, to our hurricane, earth-

quake and tsunami relief efforts of recent times, Merck has

been at our side helping to bring life-saving health care

resources and hope to the people who need them most.”

the lymphatic system. Those affected may develop kidney

damage due to blockage of the lymphatic system. The

disease is commonly known as elephantiasis because it

can lead to the disfiguring enlargement of the arms, legs

and genitals. More than 300 million people in Africa are

at risk of contracting LF.

In 1998, Merck committed to donating MECTIZAN for the

elimination of LF in African countries where it co-exists

with onchocerciasis. Merck’s MECTIZAN is a key component

of the Global Alliance for the Elimination of Lymphatic

Filariasis (GAELF), which has the goal of eliminating LF

worldwide by the year 2020. By 2006, national LF elimina-

tion programs using MECTIZAN had been established in

10 African countries, with an estimated 40 million people

receiving the medication.

The MECTIZAN Donation Program is the largest, continuing

donation program of its kind, involving a unique and

unprecedented collaboration amongst Merck, the World

Health Organization, the World Bank, UNICEF, numerous

non-governmental development organizations and

international agencies, Ministries of Health and more

MERCK MECTIZAN DONATION PROGRAM (MDP)Now marking its 20th year, the Merck MECTIZAN Donation

Program (MDP) for the treatment of onchocerciasis (river

blindness) and elimination of lymphatic filariasis is the

largest component of the MMOP. Merck decided to donate

MECTIZANTM for the treatment of river blindness for as long

as needed, wherever needed, in 1987. In 1998, Merck

expanded the MDP to include the elimination of

lymphatic filariasis in African countries where

lymphatic filariasis and onchocerciasis co-exist.

Onchocerciasis is endemic in 35 countries throughout

sub-Saharan Africa, Latin America and in Yemen, with

an estimated 120 million people in these areas at risk

of contracting the disease. The disease is caused

by a parasitic worm that is transmitted (to infected

individuals) by the bite of a black fly that breeds

in fast-flowing rivers. A debilitating parasitic disease

that causes excruciating itching and severe disfigure-

ment, onchocerciasis is a leading cause of preventable

blindness in Central and West Africa.

Merck donates MECTIZAN to non-governmental development

organizations (NGDOs) — working in conjunction with local

Ministries of Health — for the treatment of large populations

in countries where onchocerciasis is endemic. Applications

to implement community-directed treatment programs are

submitted to the MECTIZAN Donation Program Secretariat for

review and approval by the MECTIZAN Expert Committee.

The Merck MECTIZAN Donation Program has successfully reached

millions at risk in some of the poorest regions in the world.

In 2006 alone, more than 60 million people were treated for

onchocerciasis with MECTIZAN.

Lymphatic filariasis, (LF) commonly referred to as elephantiasis,

is a disease found in the tropics and sub-tropics of Africa, Asia,

the Western Pacific and parts of the Americas. The parasitic

filarial worms are transmitted by a mosquito and lodge in Photo courtesy of Interchurch Medical Assistance, Inc.







































































































































































































Documents

The Merck Medical Outreach Program · –Former U.S. President Jimmy Carter ... abroad. Donations for use in ... their on-going, humanitarian programs. Says Kara Keating, of CMMB,